Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression | 9 | 2026 | 507 | 1.340 |
Why?
|
| Depressive Disorder | 8 | 2026 | 186 | 1.260 |
Why?
|
| Health Care Costs | 5 | 2024 | 211 | 1.260 |
Why?
|
| Chronic Pain | 5 | 2024 | 133 | 1.180 |
Why?
|
| Gastroenteritis | 2 | 2024 | 16 | 1.030 |
Why?
|
| Cost-Benefit Analysis | 10 | 2023 | 237 | 0.970 |
Why?
|
| Behavior Therapy | 8 | 2026 | 125 | 0.930 |
Why?
|
| Delivery of Health Care, Integrated | 6 | 2024 | 540 | 0.920 |
Why?
|
| Cost of Illness | 2 | 2024 | 92 | 0.910 |
Why?
|
| Humans | 62 | 2026 | 17622 | 0.860 |
Why?
|
| Adolescent | 31 | 2026 | 3625 | 0.820 |
Why?
|
| Neoplasms | 6 | 2026 | 457 | 0.790 |
Why?
|
| Male | 41 | 2026 | 10014 | 0.750 |
Why?
|
| Anxiety Disorders | 7 | 2026 | 100 | 0.740 |
Why?
|
| Female | 46 | 2026 | 12715 | 0.730 |
Why?
|
| Hallucinogens | 1 | 2022 | 21 | 0.690 |
Why?
|
| Quality of Life | 7 | 2025 | 505 | 0.680 |
Why?
|
| Cannabis | 1 | 2022 | 83 | 0.630 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 226 | 0.620 |
Why?
|
| Stroke | 1 | 2022 | 309 | 0.590 |
Why?
|
| Child | 15 | 2026 | 2485 | 0.530 |
Why?
|
| Depressive Disorder, Major | 5 | 2022 | 98 | 0.520 |
Why?
|
| Middle Aged | 21 | 2026 | 7954 | 0.520 |
Why?
|
| Anxiety | 5 | 2026 | 162 | 0.490 |
Why?
|
| Early Detection of Cancer | 3 | 2026 | 559 | 0.470 |
Why?
|
| Colorectal Neoplasms | 3 | 2026 | 642 | 0.450 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2022 | 380 | 0.440 |
Why?
|
| Analgesics, Opioid | 4 | 2022 | 258 | 0.440 |
Why?
|
| Aged | 13 | 2026 | 6223 | 0.410 |
Why?
|
| Serotonin Uptake Inhibitors | 4 | 2020 | 45 | 0.410 |
Why?
|
| Binge-Eating Disorder | 2 | 2010 | 13 | 0.410 |
Why?
|
| Adult | 20 | 2026 | 7621 | 0.410 |
Why?
|
| Treatment Outcome | 13 | 2026 | 1161 | 0.380 |
Why?
|
| Young Adult | 12 | 2026 | 2538 | 0.370 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 383 | 0.370 |
Why?
|
| Psychotherapy, Brief | 2 | 2026 | 21 | 0.360 |
Why?
|
| Electronic Health Records | 6 | 2021 | 719 | 0.360 |
Why?
|
| United States | 11 | 2025 | 3922 | 0.340 |
Why?
|
| Reminder Systems | 2 | 2025 | 76 | 0.330 |
Why?
|
| Acupuncture Therapy | 3 | 2017 | 34 | 0.320 |
Why?
|
| Musculoskeletal Pain | 3 | 2017 | 26 | 0.320 |
Why?
|
| Telemedicine | 2 | 2024 | 196 | 0.320 |
Why?
|
| Chronic Disease | 3 | 2022 | 398 | 0.300 |
Why?
|
| Dental Facilities | 1 | 2009 | 1 | 0.290 |
Why?
|
| Referral and Consultation | 2 | 2017 | 161 | 0.290 |
Why?
|
| Primary Health Care | 7 | 2022 | 729 | 0.290 |
Why?
|
| Tobacco Use Cessation | 1 | 2009 | 18 | 0.290 |
Why?
|
| Health Plan Implementation | 1 | 2009 | 33 | 0.280 |
Why?
|
| Genetic Carrier Screening | 2 | 2018 | 16 | 0.280 |
Why?
|
| Combined Modality Therapy | 7 | 2014 | 114 | 0.280 |
Why?
|
| Text Messaging | 2 | 2025 | 38 | 0.280 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 2 | 2022 | 6 | 0.270 |
Why?
|
| Hotlines | 1 | 2007 | 10 | 0.270 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 1296 | 0.270 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 1157 | 0.270 |
Why?
|
| Tobacco Use Disorder | 1 | 2007 | 35 | 0.260 |
Why?
|
| Nicotine | 1 | 2007 | 27 | 0.260 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 35 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 689 | 0.260 |
Why?
|
| Smoking Cessation | 1 | 2007 | 149 | 0.240 |
Why?
|
| Medicare | 2 | 2025 | 197 | 0.240 |
Why?
|
| Antidepressive Agents | 3 | 2018 | 142 | 0.230 |
Why?
|
| Video Recording | 1 | 2025 | 15 | 0.230 |
Why?
|
| Exercise | 4 | 2021 | 538 | 0.230 |
Why?
|
| Social Security | 1 | 2005 | 1 | 0.220 |
Why?
|
| Child, Preschool | 3 | 2024 | 1455 | 0.220 |
Why?
|
| Health Services Research | 3 | 2018 | 201 | 0.220 |
Why?
|
| Community Health Centers | 1 | 2025 | 56 | 0.220 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 185 | 0.220 |
Why?
|
| Needs Assessment | 1 | 2025 | 66 | 0.220 |
Why?
|
| Taxes | 1 | 2005 | 23 | 0.220 |
Why?
|
| Rural Population | 1 | 2024 | 58 | 0.210 |
Why?
|
| History, 21st Century | 1 | 2024 | 22 | 0.210 |
Why?
|
| Occult Blood | 1 | 2025 | 162 | 0.210 |
Why?
|
| Health Care Reform | 1 | 2003 | 20 | 0.200 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2003 | 23 | 0.200 |
Why?
|
| Manipulation, Chiropractic | 2 | 2015 | 18 | 0.200 |
Why?
|
| Acute Disease | 1 | 2024 | 147 | 0.200 |
Why?
|
| Infant | 2 | 2024 | 1228 | 0.200 |
Why?
|
| Mass Screening | 2 | 2026 | 693 | 0.190 |
Why?
|
| Cohort Studies | 4 | 2022 | 2502 | 0.190 |
Why?
|
| Rotavirus | 1 | 2022 | 17 | 0.190 |
Why?
|
| Rotavirus Infections | 1 | 2022 | 33 | 0.190 |
Why?
|
| Rotavirus Vaccines | 1 | 2022 | 53 | 0.190 |
Why?
|
| Vomiting | 1 | 2022 | 11 | 0.180 |
Why?
|
| Patient Acuity | 1 | 2022 | 9 | 0.180 |
Why?
|
| Hawaii | 1 | 2022 | 62 | 0.180 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2012 | 19 | 0.170 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 93 | 0.170 |
Why?
|
| Pharmacy | 1 | 2021 | 12 | 0.170 |
Why?
|
| Accelerometry | 1 | 2021 | 57 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2017 | 107 | 0.160 |
Why?
|
| Cancer Survivors | 2 | 2019 | 115 | 0.160 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 164 | 0.160 |
Why?
|
| Oregon | 3 | 2026 | 172 | 0.160 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2018 | 41 | 0.160 |
Why?
|
| Self Care | 2 | 2011 | 144 | 0.150 |
Why?
|
| Patient Compliance | 2 | 2019 | 269 | 0.150 |
Why?
|
| Survivorship | 1 | 2019 | 12 | 0.150 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2024 | 65 | 0.150 |
Why?
|
| Railroads | 1 | 2019 | 3 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 9 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2018 | 12 | 0.140 |
Why?
|
| Health Surveys | 1 | 2019 | 242 | 0.140 |
Why?
|
| Environment Design | 1 | 2019 | 67 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 33 | 0.140 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 19 | 0.140 |
Why?
|
| Genomics | 1 | 2018 | 56 | 0.140 |
Why?
|
| Cyclohexanols | 3 | 2012 | 19 | 0.130 |
Why?
|
| Life Style | 2 | 2012 | 321 | 0.130 |
Why?
|
| Health Behavior | 3 | 2012 | 348 | 0.130 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 686 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2018 | 72 | 0.130 |
Why?
|
| Program Evaluation | 2 | 2009 | 214 | 0.130 |
Why?
|
| Internet | 2 | 2009 | 207 | 0.130 |
Why?
|
| Parents | 2 | 2020 | 301 | 0.130 |
Why?
|
| Psychology, Adolescent | 1 | 2016 | 11 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 80 | 0.120 |
Why?
|
| Drug Costs | 1 | 2016 | 32 | 0.120 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 22 | 0.120 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 27 | 0.120 |
Why?
|
| Patient Navigation | 2 | 2025 | 20 | 0.110 |
Why?
|
| Weight Loss | 2 | 2022 | 298 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2023 | 1251 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 193 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2022 | 2502 | 0.110 |
Why?
|
| Commerce | 1 | 2014 | 37 | 0.100 |
Why?
|
| Buprenorphine | 1 | 2014 | 53 | 0.100 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 26 | 0.100 |
Why?
|
| Risk Factors | 3 | 2026 | 3291 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2016 | 232 | 0.100 |
Why?
|
| Phenotype | 1 | 2013 | 154 | 0.100 |
Why?
|
| Health Maintenance Organizations | 3 | 2015 | 403 | 0.100 |
Why?
|
| Adolescent Behavior | 2 | 2012 | 123 | 0.100 |
Why?
|
| Anhedonia | 1 | 2012 | 4 | 0.090 |
Why?
|
| Counseling | 2 | 2014 | 173 | 0.090 |
Why?
|
| Bulimia | 1 | 2011 | 8 | 0.090 |
Why?
|
| Pharmacists | 2 | 2021 | 50 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 545 | 0.080 |
Why?
|
| Manuals as Topic | 1 | 2010 | 5 | 0.080 |
Why?
|
| Suicide | 1 | 2012 | 116 | 0.080 |
Why?
|
| Bone Density | 2 | 2008 | 96 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 323 | 0.080 |
Why?
|
| Overweight | 1 | 2012 | 266 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 308 | 0.070 |
Why?
|
| Diet | 2 | 2012 | 355 | 0.070 |
Why?
|
| Self-Help Groups | 1 | 2009 | 27 | 0.070 |
Why?
|
| Translational Medical Research | 1 | 2009 | 32 | 0.070 |
Why?
|
| Hospitalization | 2 | 2025 | 831 | 0.070 |
Why?
|
| Advertising as Topic | 1 | 2007 | 9 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2008 | 163 | 0.070 |
Why?
|
| Telephone | 1 | 2009 | 159 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2026 | 1295 | 0.070 |
Why?
|
| Feeding and Eating Disorders | 1 | 2007 | 16 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 193 | 0.070 |
Why?
|
| Smoking Prevention | 1 | 2007 | 35 | 0.070 |
Why?
|
| Venlafaxine Hydrochloride | 3 | 2012 | 20 | 0.070 |
Why?
|
| Health Services | 1 | 2007 | 110 | 0.060 |
Why?
|
| Northwestern United States | 2 | 2021 | 53 | 0.060 |
Why?
|
| Time Factors | 3 | 2016 | 1038 | 0.060 |
Why?
|
| Los Angeles | 1 | 2026 | 150 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 1976 | 0.060 |
Why?
|
| Investments | 1 | 2005 | 1 | 0.060 |
Why?
|
| Social Isolation | 1 | 2025 | 20 | 0.060 |
Why?
|
| California | 2 | 2025 | 2433 | 0.060 |
Why?
|
| Feces | 1 | 2025 | 89 | 0.060 |
Why?
|
| Safety-net Providers | 1 | 2025 | 55 | 0.060 |
Why?
|
| Washington | 1 | 2026 | 388 | 0.050 |
Why?
|
| Health Promotion | 1 | 2007 | 293 | 0.050 |
Why?
|
| Psychometrics | 2 | 2017 | 119 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 58 | 0.050 |
Why?
|
| Budgets | 1 | 2003 | 5 | 0.050 |
Why?
|
| Insurance Benefits | 1 | 2003 | 13 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2026 | 603 | 0.050 |
Why?
|
| Pandemics | 1 | 2026 | 295 | 0.050 |
Why?
|
| Prevalence | 1 | 2026 | 830 | 0.050 |
Why?
|
| Deductibles and Coinsurance | 1 | 2003 | 32 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 874 | 0.050 |
Why?
|
| Veterans | 1 | 2024 | 149 | 0.050 |
Why?
|
| Child Health | 1 | 2023 | 43 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 143 | 0.050 |
Why?
|
| Minority Groups | 1 | 2023 | 104 | 0.050 |
Why?
|
| Patient Health Questionnaire | 1 | 2022 | 18 | 0.040 |
Why?
|
| Drug Resistance | 2 | 2012 | 19 | 0.040 |
Why?
|
| Glycated Hemoglobin A | 1 | 2022 | 179 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 402 | 0.040 |
Why?
|
| Vital Signs | 1 | 2021 | 12 | 0.040 |
Why?
|
| Biomarkers | 2 | 2016 | 302 | 0.040 |
Why?
|
| Sleep Hygiene | 1 | 2020 | 2 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2020 | 6 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 368 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 135 | 0.040 |
Why?
|
| Activities of Daily Living | 2 | 2011 | 80 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 124 | 0.040 |
Why?
|
| Communication | 1 | 2021 | 181 | 0.040 |
Why?
|
| Mentoring | 1 | 2019 | 29 | 0.040 |
Why?
|
| Motivation | 1 | 2019 | 112 | 0.040 |
Why?
|
| Religion and Medicine | 1 | 2018 | 2 | 0.040 |
Why?
|
| Reproductive Health | 1 | 2018 | 10 | 0.030 |
Why?
|
| Income | 1 | 2018 | 86 | 0.030 |
Why?
|
| Research Design | 1 | 2020 | 337 | 0.030 |
Why?
|
| Preconception Care | 1 | 2018 | 44 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2018 | 324 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2016 | 15 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2019 | 256 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1107 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 12 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2016 | 30 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 8 | 0.030 |
Why?
|
| Models, Economic | 1 | 2016 | 17 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2012 | 959 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2016 | 33 | 0.030 |
Why?
|
| Health Resources | 1 | 2016 | 39 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2017 | 169 | 0.030 |
Why?
|
| Actigraphy | 1 | 2015 | 14 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 842 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 84 | 0.030 |
Why?
|
| Utilization Review | 1 | 2014 | 42 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 214 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 492 | 0.030 |
Why?
|
| Cognition | 1 | 2015 | 91 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 168 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 1093 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 1565 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2012 | 11 | 0.020 |
Why?
|
| Drug Substitution | 1 | 2012 | 8 | 0.020 |
Why?
|
| Affect | 1 | 2012 | 21 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 33 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 144 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 55 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2012 | 56 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 104 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 65 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 181 | 0.020 |
Why?
|
| Anorexia Nervosa | 1 | 2010 | 5 | 0.020 |
Why?
|
| Bulimia Nervosa | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cost Savings | 1 | 2010 | 20 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2010 | 50 | 0.020 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2011 | 213 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 99 | 0.020 |
Why?
|
| Retention (Psychology) | 1 | 2008 | 5 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 30 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2010 | 300 | 0.020 |
Why?
|
| Office Visits | 1 | 2007 | 75 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2006 | 4 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 73 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2006 | 56 | 0.020 |
Why?
|
| Naltrexone | 1 | 2006 | 18 | 0.020 |
Why?
|
| Comorbidity | 1 | 2007 | 552 | 0.010 |
Why?
|
Concepts
(249)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->